SCHEMBL8326422

SCHEMBL8326422

[CH2]C[C@@](N)(c1ccccc1)c1ccc(F)cc1

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 9/20 0.48
KIF11 P52732 4/20 0.42
KCNE1 P15382 1/20 0.41
KCNQ1 P51787 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.36
ALDH1A1 P00352 2/20 0.36
HTT P42858 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
KMT2A Q03164 1/20 0.36
TSHR P16473 1/20 0.36
NFE2L2 Q16236 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8327109 1.00 KCNN4 (0.48) KCNN4KIF11KCNE1KCNQ1SMN1; SMN2
SCHEMBL8321366 0.83 ALDH1A1 (0.58) KCNN4KIF11ALDH1A1TSHR
SCHEMBL8322782 0.83 ALDH1A1 (0.58) KCNN4KIF11ALDH1A1TSHR
SCHEMBL8321573 0.82 KIF11 (0.49) KCNN4KIF11NFE2L2
SCHEMBL8321948 0.82 KIF11 (0.49) KCNN4KIF11NFE2L2
SCHEMBL29001565 0.79 KCNN4 (0.53) KCNN4KIF11KCNE1KCNQ1SMN1; SMN2
SCHEMBL8322052 0.79 KIF11 (0.50) KCNN4KIF11MEN1LMNAKMT2A
SCHEMBL18435025 0.79 HTT (0.46) KCNN4KIF11KCNE1KCNQ1SMN1; SMN2
SCHEMBL5479948 0.78 KCNN4 (0.70) KCNN4KIF11KCNE1KCNQ1ALDH1A1
SCHEMBL8325626 0.78 KCNN4 (0.43) KCNN4KIF11KCNE1KCNQ1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0948496-A2 SUBSTITUTED PYRIMIDINONE AND PYRIDONE COMPOUNDS AND METHODS OF USE Amgen inc. (US) 1999-10-13 EP disclosed
WO-1998024780-A2 SUBSTITUTED PYRIMIDINONE AND PYRIDINONE COMPOUNDS AND THEIR USE AMGEN INC. (US) 1998-06-11 WO disclosed